Caribou Biosciences (CRBU) Return on Capital Employed (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Return on Capital Employed data on file, last reported at 92.42% in Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 3071.0% year-over-year to 92.42% in Q1 2026; TTM through Mar 2026 was 92.42%, a 3071.0% decrease from a year earlier, with the FY2025 full-year figure at 67.76%, down 1906.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 92.42%, roughly flat from 92.85% in the prior quarter.
• Over the last five years, Return on Capital Employed for CRBU reached as high as 18.16% in Q1 2022 and fell as low as 92.85% in Q4 2025.
• Historically, Return on Capital Employed has averaged 48.03% across 5 years, with a median of 38.54% in 2023.
• Across the five-year window, Return on Capital Employed jumped 185 bps in 2023 and tumbled 3766 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 29.71% in 2022, then climbed by 6 bps to 27.86% in 2023, then slumped by 101 bps to 55.88% in 2024, then tumbled by 66 bps to 92.85% in 2025, then advanced by 0 bps to 92.42% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 92.42% in Q1 2026, 92.85% in Q4 2025, and 88.26% in Q3 2025.